Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Mar 29, 2021 8:07pm
35 Views
Post# 32902762

RE:Biofinder, thar she blows

RE:Biofinder, thar she blowsOne of Biofinder's classic posts.  Blowhard that knew F all.


GunnerG wrote: Biofinder, your EXTENSIVE RESEARCH  gave you the insight to sell 50%.  So you kept the other 50% and welcome to PLI.

2016 - Nov 3,  when the sp dropped to $2.63, you gave us a big "thank you" after more of your EXTENSIVE RESEARCH no doubt.  You have said "thank you" ~4 times since joining PLI when the sp dropped and bought at the new low price.  The smarter investors who sold, say "thank you"

That day you also predicted/stated:
- easy double in 6+ months ( by Apr 2017)
- BLA to be filed in two weeks ( by Nov 17, 2016)  LOL
- BLA APPROVAL May 2017 (maybe May 2019)
- sp $4.00 May 2017 after APPROVAL
- NASDAQ listing, followed by US institutional investors
- many irons in the fire.  Refocusing has limited the irons.

Your such a blowhard and your research somewhat lacking.  What a blowhard.


Biofinder wrote: It was a good day to buy, which I did, so "thank you" to all the short sided investors for driving the pps down to these low levels. Now all I have to do is sit and wait 6+ months for an easy double of my money from these low pps levels of today.

The BLA for Pg is to be filed in the next couple of weeks, then 6 months of waiting until FDA approval, tic tic tic... after FDA approval the pps should cross the $4 USD threshold for the required Nasdaq listing, then the US institutional investors will be able to dump their monies into this stock as many institutions/investment houses are prohibited from investing their client's money into non Nasdaq/NYSE companies; then I can double my money, again... imo only.

This company has so many irons in the fire; the wound healing alone is proven technology and worth billions of dollars all on its own. So many off label uses for Pg alone... $$$

News is sometimes unexpected and often seems to come out of nowhere. I've been playing this game long enough to know to expect the unexpected. Day traders can make a few dollars today, but I'm betting this is a good stock to buy and hold at least until after FDA approval of Pg for a nice fat payday, all imho... but to each their own as I don't fault anyone making a buck or two.
GLTA


<< Previous
Bullboard Posts
Next >>